From: fbmm-bounces@lists.oulu.fi fbmm-bounces@lists.oulu.fi On Behalf Of Mirja Peltola Sent: maanantai 31. elokuuta 2020 15.29 To: fbmm@lists.oulu.fi Subject: [Fbmm] FW: The HiLIFE - Institute of Biotechnology, University of Helsinki, Varjosalo laboratory of Molecular Systems Biology / Pathology, invites applications for a position of Doctoral Student

Subject: The HiLIFE - Institute of Biotechnology, University of Helsinki, Varjosalo laboratory of Molecular Systems Biology / Pathology, invites applications for a position of Doctoral Student

The University of Helsinki is one of the world's leading universities for multidisciplinary research. HiLIFE Helsinki Institute of Life Science is a research institute that supports high quality life science research across the University campuses and faculties. The research activities at the Institute of Biotechnology consist of several research teams focusing on a specific area of molecular biology, cell biology or biotechnology. The Institute is situated in the Viikki science park. For more information on the Institute, please visit https://www.helsinki.fi/en/hilife-institute-of-biotechnology.

The HiLIFE - Institute of Biotechnology, Varjosalo laboratory of Molecular Systems Biology / Pathology, invites applications for a position of

Doctoral Student

The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2). COVID-19 is currently rapidly spreading worldwide to over 180 countries, including Finland. To date, no specific antiviral drugs have been developed for SARS-CoV-2. Drug discovery is hindered by the fact that viruses do not have their own metabolism, but are dependent on the host. This project is part of a consortia grant funded by the Academy of Finland, aiming to fight the ongoing pandemic of COVID-19. The project is a combination of modern technologies used to study proteomics and genomics. The candidate will apply the interaction proteomics to construct a comprehensive virus-host protein interaction network and identify the potential protein targets for testing the available drug(s) against all possible variants or mutations of SARS-COV-2. The pipeline you will set up is important not only for the SARS-COV-2 but also for many other newly emerging viruses of interest.

We are looking for a highly-motivated candidate with a master's degree in biology, biochemistry, biotechnology or other relevant fields. We expect the candidate to have practical experience with "wet lab" work and strong interest in the development and application of modern instrumentation to study host-pathogen interaction. Experience in proteomics is considered an advantage. The candidate should work well in a team as she/he will be integrated into an international research team of experts in system biology. The working language in the group is English.

More information and how to apply at https://www.helsinki.fi/en/open-positions/doctoral-student-varjosalo-laborat...

Deadline for applications is September 25, 2020.